| Abstrak/Abstract |
The preventive efficacy of MUC1‐specific DNA immunization on inflammation‐driven colon carcinogenesis in human MUC1 transgenic (MUC1.Tg) mice was investigated. Mice were vac‐ cinated with MUC1 DNA mixed with autologous bone‐marrow‐derived dendritic cells (BMDCs), and then colonic tumors were induced by azoxymethane (AOM) injection and oral administration of dextran sulfate sodium (DSS). Two types of tumors, squamous metaplasia and tubular adenoma, were observed. Both expressed high levels of MUC1 as indicated by the binding of anti‐MUC1 an‐ tibodies with different specificities, whereas MUC1 expression was not detected in normal colonic mucosa. When mice were immunized with MUC1 DNA + BMDCs, tumor incidence, tumor number, and tumor size were significantly reduced. In contrast, vaccination with MUC1 DNA alone or BMDCs alone was ineffective in reducing tumor burden. Inflammation caused by DSS was not sup‐ pressed by the MUC1 DNA + BMDCs vaccination. Furthermore, MUC1 protein expression levels, as judged by anti‐MUC1 antibody binding in tumors grown after vaccination, did not significantly differ from the control. In conclusion, an inflammation‐driven carcinogenesis model was estab‐ lished in MUC1.Tg mice, closely resembling human colon carcinogenesis. In this model, vaccination with MUC1 DNA + BMDCs was effective in overriding MUC1 tolerance and reducing the tumor burden by a mechanism not affecting the level of colonic inflammation. |
